Professional Documents
Culture Documents
Ranitidine
Ranitidine
Ranitidine
Generic Name Pharmacologic Completely inhibits action General Indication: Contraindicated in CNS: headache, malaise, vertigo Before:
Ranitidine HCl Class: of histamine and H2 – Active patients hypersensitive Assess patent for
H2 –receptor receptor sites of parietal duodenal and to drug EENT: blurred vision abdominal pain
Trade Name antagonist cells, decreasing gastric gastric ulcer Use cautiously in Inform the purpose
Zantac, Zantac acid secretion. Maintenance of the drug.
patients with hepatic Hepatic: jaundice
EFFERdose, Zantac Therapeutic Class: Check for doctor’s
therapy for dysfunction. Adjust
GELdose, Zantac-75 Antiulcer Pharmacokinetics: orders
duodenal and dosage in patients with Other: anaphylaxis, angioedema
gastric ulcer Assess for
Patient's Dose Onset: unknown impaired renal function.
hypersensitivities.
50mg q8hrs IVTT Peak: unknown Pathogenic
Check IV site
Maximum Dose Duration: unknown hypersecretory before
50 mg Half-life: 2 -3 hr conditions, such as administration.
Zollinger-Ellison
Minimum Dose Syndrome During:
25 mg Gastroesophag Explain to the
eal reflux disease patient the function
Availability Erosive of this drug.
25-50 mg IVTT esophagitis Monitor site
Heart burn frequently for
Route thrombophlebitis
IV (pain, redness, and
swelling).
Patient's Indication:
Treat patient’s esophageal After:
ulcer as seen in the Advise pt. to report
patient’s findings and at abdominal pain,
the same time, help in blood in stool or
treating the patient’s emesis, black, tarry
heartburn or GERD. stools, or coffee
ground emesis.